Alendronate improves fasting plasma glucose and insulin sensitivity, and decreases insulin resistance in prediabetic osteopenic postmenopausal women: A randomized triple-blind clinical trial.
Maryam Karimi FardAshraf AminorroayaAli KachueiMohammad Reza SalamatMoluk Hadi AlijanvandSima Aminorroaya YaminiMansoor KarimifarAwat FeiziMassoud AminiPublished in: Journal of diabetes investigation (2018)
Administration of 70 mg/week alendronate improves fasting plasma glucose, HbA1c and insulin indices in postmenopausal women.